Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.58
HLTH's Cash to Debt is ranked higher than
61% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. HLTH: 0.58 )
Ranked among companies with meaningful Cash to Debt only.
HLTH' s 10-Year Cash to Debt Range
Min: 0.01  Med: 6.86 Max: No Debt
Current: 0.58
Equity to Asset 0.47
HLTH's Equity to Asset is ranked higher than
53% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HLTH: 0.47 )
Ranked among companies with meaningful Equity to Asset only.
HLTH' s 10-Year Equity to Asset Range
Min: -0.73  Med: 0.40 Max: 0.81
Current: 0.47
-0.73
0.81
F-Score: 6
Z-Score: 4.35
M-Score: 1.41
WACC vs ROIC
8.50%
73.67%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 21.30
HLTH's Operating margin (%) is ranked higher than
88% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 7.05 vs. HLTH: 21.30 )
Ranked among companies with meaningful Operating margin (%) only.
HLTH' s 10-Year Operating margin (%) Range
Min: -315.97  Med: -10.15 Max: 64.77
Current: 21.3
-315.97
64.77
Net-margin (%) 5.53
HLTH's Net-margin (%) is ranked higher than
59% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. HLTH: 5.53 )
Ranked among companies with meaningful Net-margin (%) only.
HLTH' s 10-Year Net-margin (%) Range
Min: -320.05  Med: -40.36 Max: 9.6
Current: 5.53
-320.05
9.6
ROE (%) 20.58
HLTH's ROE (%) is ranked higher than
86% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 8.45 vs. HLTH: 20.58 )
Ranked among companies with meaningful ROE (%) only.
HLTH' s 10-Year ROE (%) Range
Min: -269.57  Med: -56.62 Max: 33.26
Current: 20.58
-269.57
33.26
ROA (%) 9.51
HLTH's ROA (%) is ranked higher than
84% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 3.44 vs. HLTH: 9.51 )
Ranked among companies with meaningful ROA (%) only.
HLTH' s 10-Year ROA (%) Range
Min: -137.22  Med: -28.11 Max: 10.46
Current: 9.51
-137.22
10.46
ROC (Joel Greenblatt) (%) 102.72
HLTH's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 15.83 vs. HLTH: 102.72 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HLTH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -769.94  Med: -18.19 Max: 266.35
Current: 102.72
-769.94
266.35
Revenue Growth (3Y)(%) 65.40
HLTH's Revenue Growth (3Y)(%) is ranked higher than
97% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. HLTH: 65.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HLTH' s 10-Year Revenue Growth (3Y)(%) Range
Min: -51.3  Med: -27.25 Max: 187.4
Current: 65.4
-51.3
187.4
» HLTH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with HLTH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 61.49
HLTH's P/E(ttm) is ranked lower than
82% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 29.60 vs. HLTH: 61.49 )
Ranked among companies with meaningful P/E(ttm) only.
HLTH' s 10-Year P/E(ttm) Range
Min: 3.71  Med: 32.51 Max: 1403.27
Current: 61.49
3.71
1403.27
Forward P/E 12.45
HLTH's Forward P/E is ranked higher than
83% of the 92 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. HLTH: 12.45 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 62.90
HLTH's PE(NRI) is ranked lower than
84% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 29.10 vs. HLTH: 62.90 )
Ranked among companies with meaningful PE(NRI) only.
HLTH' s 10-Year PE(NRI) Range
Min: 3.71  Med: 35.02 Max: 4040.73
Current: 62.9
3.71
4040.73
P/B 7.48
HLTH's P/B is ranked lower than
90% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. HLTH: 7.48 )
Ranked among companies with meaningful P/B only.
HLTH' s 10-Year P/B Range
Min: 0.26  Med: 2.46 Max: 13.7
Current: 7.48
0.26
13.7
P/S 2.91
HLTH's P/S is ranked lower than
76% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. HLTH: 2.91 )
Ranked among companies with meaningful P/S only.
HLTH' s 10-Year P/S Range
Min: 0.16  Med: 0.71 Max: 62.5
Current: 2.91
0.16
62.5
PFCF 85.60
HLTH's PFCF is ranked lower than
89% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 21.92 vs. HLTH: 85.60 )
Ranked among companies with meaningful PFCF only.
HLTH' s 10-Year PFCF Range
Min: 0.4  Med: 4.14 Max: 105
Current: 85.6
0.4
105
POCF 64.21
HLTH's POCF is ranked lower than
95% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 15.63 vs. HLTH: 64.21 )
Ranked among companies with meaningful POCF only.
HLTH' s 10-Year POCF Range
Min: 0.39  Med: 4.62 Max: 78.75
Current: 64.21
0.39
78.75
EV-to-EBIT 18.87
HLTH's EV-to-EBIT is ranked lower than
51% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 20.07 vs. HLTH: 18.87 )
Ranked among companies with meaningful EV-to-EBIT only.
HLTH' s 10-Year EV-to-EBIT Range
Min: -2305.2  Med: 3.40 Max: 144.3
Current: 18.87
-2305.2
144.3
Current Ratio 3.69
HLTH's Current Ratio is ranked higher than
91% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. HLTH: 3.69 )
Ranked among companies with meaningful Current Ratio only.
HLTH' s 10-Year Current Ratio Range
Min: 0.56  Med: 2.82 Max: 6.55
Current: 3.69
0.56
6.55
Quick Ratio 3.59
HLTH's Quick Ratio is ranked higher than
91% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. HLTH: 3.59 )
Ranked among companies with meaningful Quick Ratio only.
HLTH' s 10-Year Quick Ratio Range
Min: 0.53  Med: 2.56 Max: 6.08
Current: 3.59
0.53
6.08
Days Inventory 256.42
HLTH's Days Inventory is ranked lower than
98% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 17.87 vs. HLTH: 256.42 )
Ranked among companies with meaningful Days Inventory only.
HLTH' s 10-Year Days Inventory Range
Min: 16.82  Med: 56.21 Max: 1941.4
Current: 256.42
16.82
1941.4
Days Sales Outstanding 143.07
HLTH's Days Sales Outstanding is ranked lower than
96% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.60 vs. HLTH: 143.07 )
Ranked among companies with meaningful Days Sales Outstanding only.
HLTH' s 10-Year Days Sales Outstanding Range
Min: 26.77  Med: 71.66 Max: 183.2
Current: 143.07
26.77
183.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 39.87
HLTH's Price/Tangible Book is ranked lower than
99% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 3.78 vs. HLTH: 39.87 )
Ranked among companies with meaningful Price/Tangible Book only.
HLTH' s 10-Year Price/Tangible Book Range
Min: 1.59  Med: 5.48 Max: 43.75
Current: 39.87
1.59
43.75
Price/Projected FCF 5.59
HLTH's Price/Projected FCF is ranked lower than
88% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 1.62 vs. HLTH: 5.59 )
Ranked among companies with meaningful Price/Projected FCF only.
HLTH' s 10-Year Price/Projected FCF Range
Min: 0.05  Med: 0.21 Max: 4.86
Current: 5.59
0.05
4.86
Price/Graham Number 5.44
HLTH's Price/Graham Number is ranked lower than
87% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. HLTH: 5.44 )
Ranked among companies with meaningful Price/Graham Number only.
HLTH' s 10-Year Price/Graham Number Range
Min: 0.29  Med: 1.19 Max: 4.79
Current: 5.44
0.29
4.79
Earnings Yield (Greenblatt) (%) 5.31
HLTH's Earnings Yield (Greenblatt) (%) is ranked higher than
60% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. HLTH: 5.31 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HLTH' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.7  Med: 22.50 Max: 118.4
Current: 5.31
0.7
118.4

Analyst Estimate

Dec15 Dec16
EPS($) 0.42 0.63
EPS without NRI($) 0.42 0.63

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:NHC.Canada, NH1.Germany,
Northstar Healthcare, Inc. partners with the physicians in the development and management of ambulatory surgery centres in the United States. It manages an ambulatory surgery centre in Dallas and two pain management clinics in Houston.
» More Articles for HLTH

Headlines

Articles On GuruFocus.com
Nobilis Acquires Plano Hospital at Significant Discount; Sets Date for Financial Release and Guidanc Jul 30 2015 

More From Other Websites
Nobilis Acquires Plano Hospital at Significant Discount; Sets Date for Financial Release and... Jul 30 2015
Dr. Neil Badlani, Nobilis VP of Medical Affairs, Speaks at Prominent Symposium Jul 09 2015
Nobilis Names Kenny Klein as Chief Financial Officer Jul 09 2015
Nobilis to Join Russell Indexes; Updates on Hospital Acquisition, Texas Weather Jun 18 2015
Nobilis Launches Surgical Assist Ancillary Services Jun 08 2015
Nobilis Health Corp. Reports Record Quarterly Revenue and EBITDA May 14 2015
Nobilis Announces Closing of Bought Deal Financing of $70.6 Million May 13 2015
Nobilis Health Corp. Announces Release Date for 1st Quarter, 2015 Financial Results May 13 2015
Nobilis Health Acquires Surgical Hospital in Dallas Market May 11 2015
Nobilis Health to Host Conference Call Regarding Recent Acquisitions May 07 2015
Nobilis Announces the Acquisition of Intraoperative Neuromonitoring Company May 05 2015
Nobilis Announces Voting Results From Annual Shareholder Meeting May 01 2015
Nobilis Health Corp. Enters Into Strategic Alliance Agreement With Renew Spinal Care, LLC Apr 29 2015
Nobilis Announces Increase of Previously Announced Bought Deal Financing to C$65.9 Million Apr 21 2015
Nobilis Acquires Houston Medical Center Located Hospital Apr 20 2015
Nobilis Acquires Houston Medical Center Located Hospital Apr 20 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK